Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Gendius
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Idea== <vimeo>412347733</vimeo> Since our last successful appearance on Crowdcube last year, intellin® has established itself as a growing presence in diabetes management. In the last three months, intellin® has been downloaded over 140,000 times by those seeking better management of diabetes. The COVID-19 crisis has highlighted the need for remote home monitoring of patients. Dr Martin Marshall, (Chair, RCGP) said that ‘Having the technological capability to offer remote consultations, where appropriate, will be beneficial for general practice, the wider NHS and most importantly our patients, long after this pandemic has ended’. Intellin® has connection to over 150 medical devices and apps, and two-way communication with the Healthcare Professional via a secure dashboard leaves intellin® with the potential to play an important role going forward. We are part-way through a trial in a GP practice and are now ready to discuss our offering with the wider NHS. We are registered as an approved vendor with AstraZeneca in Saudi Arabia and aim to use this as a springboard to other opportunities. We are now planning a £5m investment round to scale the business globally and drive commercialisation. We are keen to offer this opportunity to the Crowd who have already supported the business before we then target Venture Capital for the remaining funding.
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)